Predictions
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€533.60
09.11.21
09.11.21
€600.00
09.11.22
09.11.22
38.91%
10.11.22
10.11.22
Could be worthwhile Investment >10% per year
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.70
09.11.21
09.11.21
€20.00
09.11.22
09.11.22
-62.04%
09.11.22
09.11.22
Could be very worthwhile Investment >20% year
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€6.20
19.09.22
19.09.22
-
19.09.23
19.09.23
-18.43%
08.11.22
08.11.22
Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Transgene S.A.
Start price
Target price
Perf. (%)
€2.43
07.11.21
07.11.21
€2.80
07.11.22
07.11.22
-20.58%
08.11.22
08.11.22
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.40
01.11.21
01.11.21
€15.00
01.11.22
01.11.22
79.03%
02.11.22
02.11.22
Could be worthwhile Investment >10% per year
Sanofi S.A.
Start price
Target price
Perf. (%)
€78.83
23.09.22
23.09.22
€65.00
31.12.24
31.12.24
11.65%
01.11.22
01.11.22
Could be worthwhile Investment >10% per year
Sanofi S.A.
Start price
Target price
Perf. (%)
€78.83
23.09.22
23.09.22
€65.00
31.12.24
31.12.24
11.65%
01.11.22
01.11.22
Could be worthwhile Investment >10% per year
Sanofi S.A.
Start price
Target price
Perf. (%)
€78.83
23.09.22
23.09.22
€65.00
31.12.24
31.12.24
11.65%
01.11.22
01.11.22
Could be worthwhile Investment >10% per year
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.80
24.10.22
24.10.22
€7.00
24.10.23
24.10.23
18.42%
29.10.22
29.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Aveo Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.70
18.10.22
18.10.22
-
18.10.23
18.10.23
0.78%
29.10.22
29.10.22
Capable Management
Probably not worthwhile Investment
Little innovation
Few uniques
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.54
15.10.22
15.10.22
€2.00
15.10.23
15.10.23
-0.88%
29.10.22
29.10.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
First Wave BioPharma Inc.
Start price
Target price
Perf. (%)
€8.22
15.10.22
15.10.22
€0.000
15.10.23
15.10.23
2.13%
29.10.22
29.10.22
Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€59.87
15.05.22
15.05.22
€68.00
15.05.23
15.05.23
32.12%
28.10.22
28.10.22
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€59.87
15.05.22
15.05.22
€68.00
15.05.23
15.05.23
32.12%
28.10.22
28.10.22
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€59.87
15.05.22
15.05.22
€68.00
15.05.23
15.05.23
32.12%
28.10.22
28.10.22
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Affimed N.V.
Start price
Target price
Perf. (%)
€4.14
26.02.22
26.02.22
-
26.02.23
26.02.23
-59.29%
27.10.22
27.10.22
Could be very worthwhile Investment >20% year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€70.76
26.10.21
26.10.21
€65.00
26.10.22
26.10.22
38.64%
27.10.22
27.10.22
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€70.76
26.10.21
26.10.21
€65.00
26.10.22
26.10.22
38.64%
27.10.22
27.10.22
Could be worthwhile Investment >10% per year
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.75
06.10.22
06.10.22
€0.000
06.10.23
06.10.23
-61.11%
24.10.22
24.10.22
Probably not worthwhile Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
aTyr Pharma Inc
Start price
Target price
Perf. (%)
€2.68
27.06.22
27.06.22
-
27.06.23
27.06.23
-12.04%
23.10.22
23.10.22
Could be worthwhile Investment >10% per year
Virbac S.A.
Start price
Target price
Perf. (%)
€401.50
07.11.21
07.11.21
€385.00
07.11.22
07.11.22
-38.36%
22.10.22
22.10.22
Could be worthwhile Investment >10% per year
Durect Corp.
Start price
Target price
Perf. (%)
€1.03
17.10.21
17.10.21
-
17.10.22
17.10.22
-48.06%
18.10.22
18.10.22
Probably not worthwhile Investment